Octreoscan in the differential diagnosis of ILDs

R. Carbone, V. Privitera, D. Cantalupi, R. Filiberti, M. Grosso, G. Bottino (Aosta, Genoa, Italy)

Source: Annual Congress 2003 - Interstitial lung diseases
Session: Interstitial lung diseases
Session type: Oral Presentation
Number: 1324
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Carbone, V. Privitera, D. Cantalupi, R. Filiberti, M. Grosso, G. Bottino (Aosta, Genoa, Italy). Octreoscan in the differential diagnosis of ILDs. Eur Respir J 2003; 22: Suppl. 45, 1324

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The HRCT in the diagnosis of ILDs; what’s new
Source: ERS Online Course 2019: Biopsy techniques and pathology of ILD
Year: 2019

The diagnostic value of 18F-FDG PET/CT scanning for discriminating malignant from non-malignant causes in unilateral pleural effusions
Source: International Congress 2018 – Imaging of various diseases with different imaging modalities
Year: 2018

Utility of FDG-PET in the diagnosis of pulmonary nodules
Source: Eur Respir J 2003; 22: Suppl. 45, 245s
Year: 2003

The role of FDG-PET scanning in the diagnosis of pulmonary nodules suspicious for lung cancer
Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation
Year: 2015



Clinical diagnosis, monitoring and biomarkers in ILDs
Source: ERS Course 2016
Year: 2016




Clinical diagnosis, monitoring and biomarkers in ILDs
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019


Clinical diagnosis, monitoring and biomarkers in ILDs
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018

Clinical diagnosis, monitoring and biomarkers in ILDs
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019


The Role of PET-CT in differential diagnosis of malignant-paramalignant pleural effusion
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018

The usefulness of dynamic CT and 18F-FDG PET to distinguish between benignancy and malignancy in solitary pulmonary nodule
Source: Eur Respir J 2007; 30: Suppl. 51, 532s
Year: 2007

Diagnostic work-up in patients with acute ILDs
Source: International Congress 2017 – PG11 Acute interstitial lung diseases (ILD)
Year: 2017


Image-based diagnosis of sarcoidosis
Source: Virtual Congress 2021 – Russian programme 2021
Year: 2021


HRCT in the diagnosis of diffuse lung disease - overlap issues
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010


Prognostic value of a high resolution computed tomograph (HRCT) diagnosis of usual interstitial pneumonia (UIP) compared to a histological diagnosis of UIP
Source: Eur Respir J 2001; 18: Suppl. 33, 150s
Year: 2001

Invasive approaches in the diagnosis of ILDs
Source: Virtual Congress 2020 – Interstitial lung diseases
Year: 2020


Bronchoscopy in diagnosis and staging
Source: Annual Congress 2013 –New frontiers for the bronchoscope
Year: 2013


Solid and subsolid pulmonary nodules: differential diagnosis and radiological approach to diagnosis
Source: International Congress 2018 – Imaging Grand Round
Year: 2018


HRCT imaging vs chest-x-ray assessment of endothoracal sarcoidosis extent
Source: Eur Respir J 2006; 28: Suppl. 50, 676s
Year: 2006

Scintigraphy with 99mTc-depreotide has a high sensitivity in detecting lung cancer
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007



Cytology in differential diagnosis of histological types of NSCLC
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009